Page last updated: 2024-08-22

camptothecin and Hypocalcemia

camptothecin has been researched along with Hypocalcemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chung, KY; Flombaum, C; Saltz, L; Schrag, D	1

Reviews

1 review(s) available for camptothecin and Hypocalcemia

Article	Year
Cetuximab therapy and symptomatic hypomagnesemia. Journal of the National Cancer Institute, 2005, Aug-17, Volume: 97, Issue:16 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colorectal Neoplasms; ErbB Receptors; Fatigue; Humans; Hypocalcemia; Incidence; Irinotecan; Magnesium; Magnesium Deficiency; Male; Severity of Illness Index	2005

Article

Year

Cetuximab therapy and symptomatic hypomagnesemia.

Journal of the National Cancer Institute, 2005, Aug-17, Volume: 97, Issue:16

Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colorectal Neoplasms; ErbB Receptors; Fatigue; Humans; Hypocalcemia; Incidence; Irinotecan; Magnesium; Magnesium Deficiency; Male; Severity of Illness Index

2005